Package 68071-2291-9

Brand: lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide tablets
NDC Package

Package Facts

Identity

Package NDC 68071-2291-9
Digits Only 6807122919
Product NDC 68071-2291
Description

90 TABLET in 1 BOTTLE (68071-2291-9)

Marketing

Marketing Status
Marketed Since 2020-10-30
Brand lisinopril and hydrochlorothiazide
Generic lisinopril and hydrochlorothiazide tablets
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1d783421-9b85-e31b-e063-6394a90a9493", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0368071229196"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885"], "spl_set_id": ["b2e8b3bb-0ab5-ffd7-e053-2995a90aa2b6"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (68071-2291-9)", "package_ndc": "68071-2291-9", "marketing_start_date": "20201030"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "68071-2291_1d783421-9b85-e31b-e063-6394a90a9493", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "68071-2291", "generic_name": "Lisinopril and Hydrochlorothiazide Tablets", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "10 mg/1"}], "application_number": "ANDA204058", "marketing_category": "ANDA", "marketing_start_date": "20191226", "listing_expiration_date": "20261231"}